Primary Site >> Colorectal Cancer
Gene >> IMP3
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. PMID: 19672661 |
Ref: Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. PMID: 22840368 |
Ref: Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. PMID: 24137402 |
Ref: Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target. PMID: 26244168 Ref: IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage. PMID: 26617820 |
Ref: IMP3 expression in biopsy specimens as a diagnostic biomarker for colorectal cancer. PMID: 28412210 Ref: Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. PMID: 28652767 Ref: Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer. PMID: 29344167 |
Ref: Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. PMID: 29115492 Ref: IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues. PMID: 29115542 |